Treos Bio
Treos Bio is a developer of cancer vaccines and companion diagnostics. Its platform technology uses proprietary algorithms to mine patient genetic profiles and match them to their response to therapeutic vaccines. The company has two diagnostic products: the PEPI test, a genetic test that predicts patient antigen-specific immune response and response to therapeutic cancer vaccines, approved as an IVD kit in Europe;…
Funding snapshot
About
Treos Bio is a developer of cancer vaccines and companion diagnostics. Its platform technology uses proprietary algorithms to mine patient genetic profiles and match them to their response to therapeutic vaccines. The company has two diagnostic products: the PEPI test, a genetic test that predicts patient antigen-specific immune response and response to therapeutic cancer vaccines, approved as an IVD kit in Europe; and another diagnostic test under development. The platform enables personalized cancer immunotherapy by predicting which patients will respond to specific therapeutic vaccines based on their genetic makeup. Founded in 2013 and headquartered in London, United Kingdom, Treos Bio has raised approximately 22 million at the Series B stage with investors including Luminous Ventures, ConorFund, BXR Group, SPRIM Global Investments, Hopkins Capital, and Private Capital Management.
Business model
Oncology > In-Vitro Diagnostic Tests > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Theranostics
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.